Scientific research on the International Space Station

King Faisal Specialist Hospital and Research Centre Highlights its Space Biomedical Research Journey at the Global Health Exhibition

Retrieved on: 
Sunday, October 29, 2023
Knowledge, Research, RC, Education, Exhibition, Health, Scientific research on the International Space Station, Ray (optics), Inflammation, Cell, KFSH, Tissue, King Faisal Specialist Hospital and Research Centre, Messenger, Gene, Safety, ISS, International Space Station, Interior design, Medical device

RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its pioneering journey and prospects in space biomedical research and its role in enhancing human health at the Global Health Exhibition, where KFSH&RC is also participating as a strategic healthcare partner.

Key Points: 
  • RIYADH, Saudi Arabia, Oct. 29, 2023 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its pioneering journey and prospects in space biomedical research and its role in enhancing human health at the Global Health Exhibition, where KFSH&RC is also participating as a strategic healthcare partner.
  • At the Exhibition, KFSH&RC delves into its groundbreaking experience leading four research experiments in cell sciences in space.
  • KFSH&RC is actively pursuing further research in space biomedical science to gain a more comprehensive understanding of the effects of gravity deficiency and cosmic radiation on the human body.
  • They aim to leverage the unique space environment, which provides opportunities for medical experiments that are not feasible on Earth.

Redwire Announces First Spaceflight Mission for New Cutting-Edge Pharmaceutical Drug Development Lab, Partnering with Eli Lilly and Company to Expand Space Research to Study Heart Disease and Diabetes

Retrieved on: 
Monday, October 30, 2023
Research, Pharmaceutical, Technology, Satellite, Science, Engineering, Cardiology, Biotechnology, Aerospace, Manufacturing, Health, Diabetes, 3D, Lilly, Eli Lilly and Company, NYSE, Life, Scientific research on the International Space Station, RDW, PIL, Drug development, Redwire, Environment, Tissue, Drug discovery, Partnership, BFF, Corporation, Orbit, NASA, Pain, Patient, ISS, Cardiovascular disease, Insulin, International Space Station, Pharmaceutical industry

The new platform will launch onboard SpaceX’s 29th cargo resupply services mission (SpaceX-29) for NASA to the International Space Station (ISS).

Key Points: 
  • The new platform will launch onboard SpaceX’s 29th cargo resupply services mission (SpaceX-29) for NASA to the International Space Station (ISS).
  • On the inaugural PIL-BOX-01 mission, Eli Lilly and Company (Lilly) is partnering with Redwire to conduct three critical experiments focused on developing advanced treatments for diabetes, cardiovascular disease, and pain.
  • “PIL-BOX presents us with a brand-new capability for developing critical, life-saving treatments, like insulin, for diseases like diabetes and heart disease.
  • PIL-BOX technology builds from Redwire’s multi-decade space crystallization flight heritage, which dates back to the space shuttle era through its Advanced Space Experiment Processor.

Microbes, Mucus, and Brain Organoids--Experiments to Prevent and Treat Disease Launching on Next Space Station Resupply Mission

Retrieved on: 
Monday, October 30, 2023
Ageing, Commercial Resupply Services, United States Naval Research Laboratory, EDT, Organoid, Therapy, ISS National Lab, Scientific research on the International Space Station, Behavior, Biotechnology, EST, Ray (optics), SpaceX, White lung, Infection, Research, Mucus, SpaceX Dragon, Redwire, Dementia, University, Laboratory, Disease, Immune system, Risk, SPACE, University of California, San Diego, Brain, Medication, NASA, Alzheimer's disease, Patient, ISS, Boeing, NSF, International Space Station, Communications satellite, Pharmaceutical industry

Results may provide insights to mitigate the risk of infection on future space missions and space platforms.

Key Points: 
  • Results may provide insights to mitigate the risk of infection on future space missions and space platforms.
  • The U.S. National Science Foundation (NSF) continues its collaboration with the ISS National Lab by funding two biotechnology investigations on this mission.
  • An investigation from the University of California, San Diego, which builds on previous space station research, will explore microgravity's effects on stem-cell derived brain organoids.
  • This investigation aims to study accelerated aging in space to understand how cognitive decline happens in the human brain.

Defender Pharmaceuticals Announces Collaboration with NASA on Two Phase 2 Clinical Trials Investigating DPI-386’s Ability to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

Retrieved on: 
Tuesday, October 24, 2023
Astronaut, Knowledge, Comment, Johnson Space Center, Polaris Dawn, Health, Motion sickness, Inspiration4, Scientific research on the International Space Station, Human, Orion, SpaceX, Doctor of Philosophy, Research, PVT, Spaceflight, National Aeronautics and Space Act, Contribution, International Space Station, NASA, Motion, Pharmaceutical industry, Dietary supplement, Mars

First study evaluates DPI-386 alone and in combination with sensory augmentation to effectively mitigate motion sickness and improve task performance, in comparison to placebo.

Key Points: 
  • First study evaluates DPI-386 alone and in combination with sensory augmentation to effectively mitigate motion sickness and improve task performance, in comparison to placebo.
  • Second study evaluates the feasibility and efficacy of administering DPI-386 in operational field settings, with both astronaut and ground-control subjects, when exposed to provocative motion.
  • Both trials are being led by primary investigator Scott J Wood, PhD of NASA, and Neuroscience Laboratory Principal Investigator.
  • As the only clinical pharmacologist at NASA, Dr. Putcha was responsible for directing and conducting the research and development program for optimizing pharmacotherapeutics in space.

ISS National Lab Research Announcement Seeking Tissue Engineering and Biomanufacturing Proposals Opens

Retrieved on: 
Wednesday, October 4, 2023
Tissue, ISS National Lab, SPACE, Knee, Redwire, Neurodegenerative disease, Commercial Resupply Services, International Space Station, BFF, Cartilage, Research, Science, Regenerative medicine, Parkinson's disease, NASA, Patient, LEO, Drug discovery, Diagnosis, B cell, Scientific research on the International Space Station, Health, Step, Environment, ISS, Disease, Pharmaceutical industry

KENNEDY SPACE CENTER, Fla., Oct. 4, 2023 /PRNewswire/ -- A new research announcement to leverage the unique environment of the International Space Station (ISS) to advance tissue engineering and biomanufacturing is now open.

Key Points: 
  • KENNEDY SPACE CENTER, Fla., Oct. 4, 2023 /PRNewswire/ -- A new research announcement to leverage the unique environment of the International Space Station (ISS) to advance tissue engineering and biomanufacturing is now open.
  • The ISS National Laboratory® is soliciting concepts for applied research and technology development for regenerative medicine applications seeking to demonstrate space-based manufacturing and production activities for terrestrial applications.
  • Both NASA and the ISS National Lab have prioritized utilization of the space station for in-space production applications and manufacturing opportunities, and this research announcement reflects a desire to build on this growing area of emphasis.
  • The ISS National Lab is seeking proposals in the areas of regenerative medicine and biofabrication as well as associated technologies that may benefit from the unique conditions on the space station.

Studying Immune Cell Aging in Space May Lead to New Therapies for Patients on Earth

Retrieved on: 
Tuesday, October 3, 2023
Infection, ISS National Lab, SPACE, Immunity (medical), International Space Station, Research, Key, United States national laboratories, Secrecy, Immune system, Patient, Conditional sentence, Bacteria, Scientific research on the International Space Station, Virus, ISS, Disease, Vaccine, Upward

But for the elderly and those facing chronic diseases, the immune system can wear down over time.

Key Points: 
  • But for the elderly and those facing chronic diseases, the immune system can wear down over time.
  • To better understand the relationship between immune aging and how the body heals itself, a team of scientists took their research to new heights by leveraging the International Space Station (ISS) National Laboratory to study microgravity's effects on immune cell function.
  • As people age, their immune system function declines gradually over time, which makes them increasingly vulnerable to infection and disease.
  • This makes the unique conditions of the space station an ideal platform for studying the immune aging process.

USRA Scientist Secures NASA Grant to Probe Profound Effects of Deep Space Environment on Biological Systems

Retrieved on: 
Thursday, September 28, 2023
Heart, Orion (spacecraft), Human, Universities Space Research Association, Drosophila melanogaster, International Space Station, Artemis 2, Brain, Science, USRA, Spacecraft, NASA, Artemis, LEO, Knowledge, Scientific research on the International Space Station, Environment, Communications satellite

WASHINGTON, Sept. 28, 2023 /PRNewswire/ -- NASA recently awarded Dr. Janani Iyer, a scientist at Universities Space Research Association (USRA), a three-year flight grant to investigate the effects of deep space on Drosophila melanogaster (fruit flies) spanning multiple generations.

Key Points: 
  • WASHINGTON, Sept. 28, 2023 /PRNewswire/ -- NASA recently awarded Dr. Janani Iyer, a scientist at Universities Space Research Association (USRA), a three-year flight grant to investigate the effects of deep space on Drosophila melanogaster (fruit flies) spanning multiple generations.
  • Unlike the relatively protected environment of Low Earth Orbit (LEO) environment, deep space (beyond Earth's magnetosphere) subjects astronauts to significantly higher rates of ionizing radiation—approximately ten times greater.
  • Replicating deep space radiation in Earth-based analog facilities or on the International Space Station is challenging since it cannot be accurately replicated.
  • However, the upcoming Artemis II mission provides a unique opportunity to study biological responses associated with the deep space environment.

Redwire BioFabrication Facility Successfully Prints First Human Knee Meniscus on ISS, Paving the Way for Advanced In-Space Bioprinting Capabilities to Benefit Human Health

Retrieved on: 
Thursday, September 7, 2023
Biotechnology, Other Manufacturing, General Health, Health, Health Technology, Aerospace, Manufacturing, Other Health, Luther Forest Technology Campus, Biofabrication, RDW, Redwire, Orbit, 3D bioprinting, Tear resistance, BFF, Uniformed Services University of the Health Sciences, Multimedia, Research, International Space Station, Regenerative medicine, Corporation, NASA, University of Texas Health Science Center at San Antonio, LEO, SpaceX, Injury, Meniscus, Scientific research on the International Space Station, Credit, NYSE, ISS, 3D printing, Communications satellite

This milestone opens the door to improved treatments for meniscal injuries, one of the most common injuries for U.S. Service Members.

Key Points: 
  • This milestone opens the door to improved treatments for meniscal injuries, one of the most common injuries for U.S. Service Members.
  • View the full release here: https://www.businesswire.com/news/home/20230907832309/en/
    Redwire’s 3D BioFabrication Facility successfully 3D printed the first human knee meniscus on the International Space Station, paving the way for advanced in-space bioprinting capabilities to benefit human health.
  • (Credit: Redwire)
    “This is a groundbreaking milestone with significant implications for human health,” said Redwire Executive Vice President John Vellinger.
  • Redwire has developed 20 research facilities for the ISS with 10 currently operating on station to deliver world-leading research.

SpaceX's Dragon Spacecraft Returns Crew and Critical Science to Earth Following Long-Duration Mission

Retrieved on: 
Tuesday, September 5, 2023
National Center for Atmospheric Research, Tissue, ISS National Lab, SpaceX Crew-6, University, Therapy, Commercial Crew Program, SPACE, Berkeley, Stanford University, Redwire, NCATS, Porosity, International Space Station, Research, Bangladesh Technical Education Board, Facial muscles, Science, Publication, NASA, SpaceX Dragon, Gene, SpaceX, Scientific research on the International Space Station, NIH, National Center for Advancing Translational Sciences, ISS, Communications satellite, Pharmaceutical industry, 3D printing

During their time in space, the crew members worked on dozens of research investigations and technology demonstration projects that were sponsored by the ISS National Laboratory.

Key Points: 
  • During their time in space, the crew members worked on dozens of research investigations and technology demonstration projects that were sponsored by the ISS National Laboratory.
  • The return of the Dragon spacecraft marked the conclusion of SpaceX's 6th rotational crewed mission to the orbiting laboratory under NASA's Commercial Crew Program.
  • Results from these studies will bring value to humanity, further our ability to explore, and enable a robust market in low Earth orbit.
  • The tissue sample returned with the crew, and its properties will be further analyzed on Earth.

Sierra Space and Redwire Partner to Bring In-Space Biotech Facilities to Customers via the Sierra Space Platform

Retrieved on: 
Monday, August 21, 2023
Research, Pharmaceutical, Hardware, Technology, Satellite, Science, Biotechnology, Aerospace, Other Technology, Manufacturing, Other Science, Health, Sierra Nevada Corporation, Orbital, Partnership, Scientific research on the International Space Station, RDW, International Space Station, History, Sierra, NASA, Automation, LEO, Robotics, NYSE, ISS, Fine chemical, Redwire

Sierra Space , a leading pureplay commercial space company building the first end-to-end business and technology platform in space, announced today its strategic partnership with Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy.

Key Points: 
  • Sierra Space , a leading pureplay commercial space company building the first end-to-end business and technology platform in space, announced today its strategic partnership with Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy.
  • Specifically, the two companies are collaborating on groundbreaking commercial pharmaceutical and biotech R&D and manufacturing in low-Earth orbit (LEO).
  • “In Redwire, we have a partner that has a proven history of innovation across in-space manufacturing and biotech facilities.
  • Sierra Space’s LIFE habitat launches on a conventional rocket and expands to the size of a three-story building on-orbit.